Form DEL AM - Delaying amendment
15 5월 2024 - 5:46AM
Edgar (US Regulatory)
May 14, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|
Re: |
Atossa Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-279367) |
Ladies and Gentlemen:
We are filing this letter in order to provide the staff of the Division of Corporation Finance sufficient time to perform its customary screening and review of
registration statements prior to their effectiveness.
Pursuant to Rule 473(c) of the Securities Act of 1933 (the Act), the following delaying
amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement on Form S-3 (File No. 333-279367) filed
by Atossa Therapeutics, Inc. on May 13, 2024:
The Registrant hereby amends this Registration Statement on such date or dates as may be
necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
If you have any questions or comments in connection with this delaying amendment, please contact Ryan A. Murr (415-393-8373) of Gibson, Dunn & Crutcher LLP.
[Signature page follows]
107 Spring Street, Seattle, WA 98104
|
Kind regards, |
|
/s/ Heather Rees |
Heather Rees |
Senior Vice President, Finance & Accounting |
Atossa Therapeutics, Inc. |
cc: |
Ryan A. Murr, Gibson, Dunn & Crutcher LLP |
107 Spring Street, Seattle, WA 98104
Atossa Therapeutics (NASDAQ:ATOS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Atossa Therapeutics (NASDAQ:ATOS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024